Advertisement
UK markets close in 3 hours 9 minutes
  • FTSE 100

    8,144.66
    +0.53 (+0.01%)
     
  • FTSE 250

    19,925.83
    -39.56 (-0.20%)
     
  • AIM

    764.41
    +3.67 (+0.48%)
     
  • GBP/EUR

    1.1695
    -0.0013 (-0.11%)
     
  • GBP/USD

    1.2483
    -0.0013 (-0.11%)
     
  • Bitcoin GBP

    46,429.95
    -2,477.32 (-5.07%)
     
  • CMC Crypto 200

    1,242.52
    -96.55 (-7.21%)
     
  • S&P 500

    5,035.69
    -80.48 (-1.57%)
     
  • DOW

    37,815.92
    -570.17 (-1.49%)
     
  • CRUDE OIL

    80.41
    -1.52 (-1.86%)
     
  • GOLD FUTURES

    2,307.30
    +4.40 (+0.19%)
     
  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     
  • HANG SENG

    17,763.03
    +16.12 (+0.09%)
     
  • DAX

    17,932.17
    -186.15 (-1.03%)
     
  • CAC 40

    7,984.93
    -80.22 (-0.99%)
     

Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1

VAUGHAN, Ontario, April 15, 2024--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter 2024 financial results on Wednesday, May 1, 2024. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.

Conference Call Details

Date:

 

Wednesday, May 1, 2024

 

Time:

 

8 a.m. ET

 

Webcast:

 

https://www.webcaster4.com/Webcast/Page/2883/49631

 

Participant Event Dial-in:

 

+1 (888) 506-0062 (North America)

+1 (973) 528-0011 (International)

 

Participant Access Code:

 

357966

 

Replay Dial-in:

 

+1 (877) 481-4010 (North America)

+1 (919) 882-2331 (International)

 

Replay Passcode:

 

49631 (replay available until May 15, 2024)

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on X, LinkedIn, Facebook and Instagram.

ADVERTISEMENT

© 2024 Bausch + Lomb.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240415028295/en/

Contacts

Media Contact:
T.J. Crawford
tj.crawford@bausch.com
(908) 705-2851

Investor Contact:
George Gadkowski
george.gadkowski@bausch.com
(877) 354-3705 (toll free)